These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30041680)

  • 21. Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology.
    Van Holsbeke C; Van Belle V; Leone FP; Guerriero S; Paladini D; Melis GB; Greggi S; Fischerova D; De Jonge E; Neven P; Bourne T; Valentin L; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2010 Jul; 36(1):81-7. PubMed ID: 20217895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study.
    Van Calster B; Valentin L; Van Holsbeke C; Zhang J; Jurkovic D; Lissoni AA; Testa AC; Czekierdowski A; Fischerová D; Domali E; Van de Putte G; Vergote I; Van Huffel S; Bourne T; Timmerman D
    Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2420-8. PubMed ID: 21908724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of the 'ovarian crescent sign' in the evaluation of adnexal masses.
    Kushtagi P; Kulkarni KK
    Singapore Med J; 2008 Dec; 49(12):1017-20. PubMed ID: 19122954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
    Li PL; Zhang X; Li TF; Wang LL; Du LT; Yang YM; Li J; Wang HY; Zhang Y; Wang CX
    Clin Chim Acta; 2015 Jan; 439():148-53. PubMed ID: 25445414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
    Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
    Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface-enhanced Raman scattering detection of lysophosphatidic acid.
    Seballos L; Zhang JZ; Sutphen R
    Anal Bioanal Chem; 2005 Nov; 383(5):763-7. PubMed ID: 16261318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adnexal masses in women with breast cancer.
    Tuncer ZS; Boyraz G; Selcuk I; Sahin N; Kaynaroğlu V; Ozışık Y
    Aust N Z J Obstet Gynaecol; 2012 Jun; 52(3):266-9. PubMed ID: 22486200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and Management of Adnexal Masses.
    Biggs WS; Marks ST
    Am Fam Physician; 2016 Apr; 93(8):676-81. PubMed ID: 27175840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raman spectroscopic techniques to detect ovarian cancer biomarkers in blood plasma.
    Paraskevaidi M; Ashton KM; Stringfellow HF; Wood NJ; Keating PJ; Rowbottom AW; Martin-Hirsch PL; Martin FL
    Talanta; 2018 Nov; 189():281-288. PubMed ID: 30086919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-bridged silver nanoparticle assemblies for highly sensitive molecular recognition of sialic acid on cancer cells via surface-enhanced raman scattering spectroscopy.
    Deng R; Yue J; Qu H; Liang L; Sun D; Zhang J; Liang C; Xu W; Xu S
    Talanta; 2018 Mar; 179():200-206. PubMed ID: 29310222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative tumor markers in the diagnosis of ovarian cancer.
    Karakaya BK; Başer E; Bildacı B; Cömert EÇ; Bayraktar N; Dursun P; Kuşçu E; Ayhan A
    Ginekol Pol; 2016; 87(8):565-769. PubMed ID: 27629130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
    Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors.
    Watrowski R; Heinze G; Jäger C; Forster J; Zeillinger R
    Tumour Biol; 2016 Sep; 37(9):12079-12087. PubMed ID: 27207344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Jul; 30(3):e333-40. PubMed ID: 25704505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Difficulties in differential diagnosis of adnexal masses during pregnancy: the role of greyscale and color doppler sonography].
    Czekierdowski A; Bednarek W; Rogowska W; Kotarski J
    Ginekol Pol; 2001 Dec; 72(12A):1281-6. PubMed ID: 11883264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Preoperative Scoring System for Adnexal Mass in Children and Adolescents to Preserve Their Future Fertility.
    Depoers C; Martin FA; Nyangoh Timoh K; Morcet J; Proisy M; Henno S; Lavoue V; Arnaud AP
    J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):57-63. PubMed ID: 30205159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prospective External Validation of International Ovarian Tumor Analysis (IOTA) Simple Rules in the Hands of Level I and II Examiners.
    Knafel A; Banas T; Nocun A; Wiechec M; Jach R; Ludwin A; Kabzinska-Turek M; Pietrus M; Pitynski K
    Ultraschall Med; 2016 Oct; 37(5):516-523. PubMed ID: 26126150
    [No Abstract]   [Full Text] [Related]  

  • 39. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
    Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of new Tumor Marker Age Score in clinical practice: Validity evaluation for differentiation benign from malignant adnexal masses.
    Ladjević IL; Terzić M; Ladjević N; Dotlić J; Pilić I; Bila J; Knezević N; Milenković S; Maricić S; Arsenović N; Brndusić N; Nikolić B
    Acta Chir Iugosl; 2012; 59(3):49-56. PubMed ID: 23654006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.